A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal Subjects
Status:
Recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
This study is being conducted to evaluate the safety and tolerability of single ascending and
multiple ascending oral doses of NIP292 tablets administered following an overnight fast in
healthy adult subjects.
Phase:
Phase 1
Details
Lead Sponsor:
The National Institutes of Pharmaceutical R&D Co. Ltd, China